Potential Side Effects and Considerations While peptide therapy is generally well-tolerated, it is important to be aware of potential side effects and considerations
The staff has advised against allowing for broader pharmacy compounding of the seven peptides, saying there is scant evidence to support their safety and effectiveness
Clinical context, lab findings, and patient goals guide not only if peptides are appropriate, but which peptide and how to deliver it
TB-500 is a fragment of Thymosin Beta-4 and is studied for systemic effects: cell migration, anti-inflammatory signaling, and progenitor-cell mobilization
J Am Coll Nutr 1998;17:235-8
The Billon 2025 paper (PMID 41421047) introduced SLU-PP-915 as an "orally active" sibling specifically because the parent SLU-PP-332 "lacks oral bioavailability." Despite that, the most common vendor formats are oral capsules and tablets products without published evidence that they produce systemic ERR agonism in humans
